IRCT20200623047902N40招募中Unknown
Bioequivalence study of Lansoprazole 30 mg manufactured by Actover Co. versus originator brand in healthy volunteers in fasting condition
Actover Co0 个研究点目标入组 24 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- Unknown
- 状态
- 招募中
- 发起方
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 55 years（—）
- 性别
- All
入选标准
- •General Health (Liver, Heart, and Kidney)
- •Body Mass Index (18-28)
- •Informed consent
- •Age (18-55 years old)
排除标准
- •History of cardiovascular disease
- •History of liver and kidney disease
- •Alcoholism and Narcoticism
- •History of allergy to lansoprazole
研究者
相似试验
尚未招募
Unknown
Comparative in vivo evaluation of 2 ?Lansoprazole 30 mg Capsule formulations.Eosinophilic esophagitisIRCT20180620040164N66Dorsa Pharmaceutical Co.24
尚未招募
不适用
Bioequivalence study of Pantoprazole 40mgHealthy volunteers.IRCT20200623047902N7Sanamed pharma company24
尚未招募
Unknown
Bioequivalence study of Pantoprazole 40 mg tabletThis study is performed on healthy volunteers..IRCT20200623047902N33Ronak Pharm company24
招募中
不适用
Study of absorption and elimination rate of omeprazole 20 mg capsule in comparison with omeprazole brand capsules (Prilosec®).bioequivalence study.IRCT20200407046981N19Yas Kavir Meybod Pharmaceutical Company24
尚未招募
不适用
Study of absorption and elimination rate of omeprazole 10-mg Sachet in comparison with omeprazole brand Sachet (Nexium®).IRCT20200407046981N20Kimia Kala Razi Pharmaceutical Company24